1823 related articles for article (PubMed ID: 17408649)
21. TLR4 monoclonal antibody blockade suppresses dextran-sulfate-sodium-induced colitis in mice.
Liu Y; Zhang Z; Wang L; Li J; Dong L; Yue W; Chen J; Sun X; Zhong L; Sun D
J Gastroenterol Hepatol; 2010 Jan; 25(1):209-14. PubMed ID: 19929926
[TBL] [Abstract][Full Text] [Related]
22. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
23. Antioxidants as novel therapy in a murine model of colitis.
Oz HS; Chen TS; McClain CJ; de Villiers WJ
J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
25. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
26. Reactivation of inflammatory bowel disease in a mouse model of depression.
Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
Cooper HS; Murthy SN; Shah RS; Sedergran DJ
Lab Invest; 1993 Aug; 69(2):238-49. PubMed ID: 8350599
[TBL] [Abstract][Full Text] [Related]
29. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
31. Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis.
Cho EY; Choi SC; Lee SH; Ahn JY; Im LR; Kim JH; Xin M; Kwon SU; Kim DK; Lee YM
Int Immunopharmacol; 2011 Apr; 11(4):412-7. PubMed ID: 21187179
[TBL] [Abstract][Full Text] [Related]
32. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
[TBL] [Abstract][Full Text] [Related]
33. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.
Van der Sluis M; De Koning BA; De Bruijn AC; Velcich A; Meijerink JP; Van Goudoever JB; Büller HA; Dekker J; Van Seuningen I; Renes IB; Einerhand AW
Gastroenterology; 2006 Jul; 131(1):117-29. PubMed ID: 16831596
[TBL] [Abstract][Full Text] [Related]
34. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
[TBL] [Abstract][Full Text] [Related]
35. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
36. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.
Sun X; Yamada H; Yoshihara K; Awaya A; Yoshikai Y
Int Immunopharmacol; 2007 Jul; 7(7):928-36. PubMed ID: 17499195
[TBL] [Abstract][Full Text] [Related]
37. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.
Ito R; Kita M; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Iwakura Y; Okanoue T; Yoshikawa T; Kataoka K; Mazda O
Biochem Biophys Res Commun; 2008 Dec; 377(1):12-6. PubMed ID: 18796297
[TBL] [Abstract][Full Text] [Related]
38. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
39. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
[TBL] [Abstract][Full Text] [Related]
40. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
Martín AR; Villegas I; Alarcón de la Lastra C
Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
